ByHeart, Inc.

New York, NY · Founded 2017 · Biotech · Still private

Nutritionally optimized infant formula with novel composition

Updated · byheart.com

Sector
Biotech
Headquarters
New York, NY
Founded
2017
Latest Form D
$72M, Mar 2025
Total capital
$361M
Grants
—
No SBIR or STTR on record
Sector median 1 award
Raised
$361M
6 Form D · Mar 2025
19 months since last filing
Contracts
—
No federal contracts on record
Patents
12
1 granted · 11 pending
6.0× sector median 2 patents

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history, newest first
DateEventSourceAmount
Private capital raisedForm D · SEC$72,177,578
Private capital raisedForm D · SEC$80,046,633
Private capital raisedForm D · SEC$29,639,049
Private capital raisedForm D · SEC$60,589,470
Private capital raisedForm D · SEC$96,885,369
Private capital raisedForm D · SEC$22,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1089Rattan Life Science Inc.——
1090KOI BIOTHERAPEUTICS INC.——
1091VIVERE ONCOTHERAPIES, INC.——
1092ByHeart, Inc.—$361M
1093BIOTECERA INC.——
1094Sidera Bio——
1095ROUND TABLE RESEARCH, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 22 related persons
  • Elizabeth AbramsDirector
  • Elias AoukarExecutive Officer
  • James BauersmithExecutive Officer
  • Arie BelldegrunDirector
  • Ron BelldegrunDirector · Executive Officer · Promoter
  • Joshua BradleyDirector
  • Tommy BurkeDirector
  • Mia FuntDirector · Executive Officer · Promoter
Show all 22 people
  • Joshua KazamDirector
  • Georg Krause-VilmarExecutive Officer
  • Devon KuehnExecutive Officer
  • Anton LinderumDirector
  • Niall MullaneExecutive Officer
  • Guy OranimDirector
  • Robert PeruzziExecutive Officer
  • Amy SchulmanDirector
  • Allan SebbagExecutive Officer
  • Denice TorresDirector
  • Michael TullyDirector
  • Saloni VarmaExecutive Officer
  • Raphael WallanderDirector
  • Hemi ZuckerDirector

Patents

USPTO · 1 granted of 12
  • Fatty Acid Compositionsapplication
  • Fatty Acid Compositionsapplication
  • Formulations For Nutritional Support In Subjects In Need Thereofapplication
  • Formulations for Nutritional Support in Subjects in Need Thereofgranted
  • Formulations For Nutritional Support In Subjects In Need Thereofapplication
  • Formulations for Nutritional Support in Subjects in Need Thereofapplication
  • Formulation Comprising Heat-treated Lactoferrin For Nutritional Support In Subjects In Need Thereofapplication
  • Nutritional Supplement Comprising Lactoferrin Protein Complexes In Subjects In Need Thereofapplication
  • Nutritional Supplement Comprising Lactoferrin Protein Complexes In Subjects In Need Thereofapplication
  • Formulation Comprising Heat-treated Lactoferrin For Nutritional Support In Subjects In Need Thereofapplication
  • Fatty Acid Compositionsapplication
  • Fatty Acid Compositionsapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.